Multi-Omics and AI Transform Disease Research Across Cancer and Neurodegeneration

This special journal volume represents a landmark collection showcasing how the convergence of multi-omics technologies, artificial intelligence, and systems biology is fundamentally reshaping biomedical research. The comprehensive compilation addresses eight critical disease areas: cancer, inflammatory and infectious diseases, neurodegeneration, cardiovascular health, autophagy, respiratory disease, and heme biology.

The featured studies demonstrate groundbreaking applications of integrative methodologies that are simplifying our understanding of complex disease mechanisms. Notable advances include spatial omics applications in colorectal cancer research, ferroptosis investigations in asthma and sepsis, and innovative proteogenomics approaches. These technologies are enabling unprecedented insights into redox biology, lipidomics, and machine learning applications in pathophysiology.

The research emphasizes translational power through network analysis and validation studies, moving beyond basic discovery toward clinical applications. The volume highlights how these integrated approaches are accelerating biomarker discovery and revealing new therapeutic targets across diverse disease states.

Critically, the collection addresses major implementation challenges including standardization requirements, ethical considerations for AI integration, and global infrastructure disparities that must be overcome for widespread adoption. The authors position this work as establishing a roadmap toward precision medicine where diagnostics, therapies, and prognoses can be tailored to each patient's unique molecular profile, representing a paradigm shift toward truly personalized healthcare innovation.